Introduction to Biotechnology, Enzyme Technology, Biosensors & Genetic Engineering Basics
This foundational unit introduces biotechnology in the pharmaceutical context and covers key enabling technologies: enzyme immobilization (methods and applications), biosensors (principles and pharmaceutical applications), protein engineering basics, industrial enzyme production, and the fundamental principles of genetic engineering that underpin modern biopharmaceuticals.
Syllabus & Topics
- 1Introduction to Biotechnology: Biotechnology = use of biological systems, living organisms, or their derivatives to develop products and processes for specific use. EU definition: ‘application of science and technology to living organisms to alter living or non-living materials for production of knowledge, goods, and services.’ Color classification: Red (medical/pharmaceutical), Green (agricultural), White (industrial), Blue (marine). Pharmaceutical biotechnology: recombinant proteins (Insulin, Interferons), monoclonal antibodies (Rituximab), vaccines (Hepatitis B), diagnostics (ELISA, PCR), gene therapy, biosimilars.
- 2Enzyme Biotechnology – Overview: Enzymes: biological catalysts — highly specific, efficient, work under mild conditions (37°C, neutral pH). Limitations of free enzymes: unstable, cannot be reused, difficult to separate from product. Solution: Enzyme Immobilization = attachment of enzyme to an insoluble support (matrix/carrier) or confinement within a defined space. Benefits: reusability (↓cost), ↑stability (thermal, pH), easy separation from product, continuous process operation, controlled product formation.
- 3Enzyme Immobilization – Methods: (1) Physical Adsorption: enzyme adsorbed onto carrier surface by weak forces (van der Waals, H-bonds, hydrophobic interactions). Carriers: alumina, silica, activated carbon, cellulose, ion-exchange resins. Simple, mild, but enzyme may leach. (2) Covalent Bonding: enzyme chemically bonded to activated carrier through functional groups (–NH₂, –SH, –OH of amino acid side chains). Carriers: CNBr-activated Sepharose, glutaraldehyde-activated glass. Strong binding → no leaching, but may distort active site. (3) Entrapment: enzyme physically trapped within a polymer matrix or microcapsule. Gel entrapment: polyacrylamide, alginate, κ-carrageenan. Fiber entrapment. Microencapsulation: enzyme inside semi-permeable membrane. Enzyme cannot leach, but substrate must diffuse in. (4) Cross-linking: enzyme molecules cross-linked to each other using bifunctional reagent (glutaraldehyde). No carrier needed → CLEAs (Cross-Linked Enzyme Aggregates). High enzyme loading but harsh conditions may denature.
- 4Applications of Immobilized Enzymes: (1) Pharmaceutical: Penicillin acylase (immobilized) → conversion of Penicillin G to 6-APA (key intermediate for semi-synthetic penicillins) — largest industrial application. Glucose isomerase → fructose production (HFCS). Aminoacylase → resolution of racemic amino acids. (2) Diagnostics: glucose oxidase in blood glucose biosensors. (3) Food industry: lactase (immobilized) for lactose-free milk. (4) Bioreactors: packed bed reactors, fluidized bed reactors with immobilized enzymes for continuous conversion.
- 5Biosensors – Principle: A biosensor = biological recognition element + transducer + signal processor. Biological element: enzyme, antibody, nucleic acid, cell, tissue → specifically interacts with analyte. Transducer: converts biological response into measurable signal. Types of transducers: Electrochemical (amperometric, potentiometric), Optical (fluorescence, SPR), Piezoelectric (mass-based), Thermal (calorimetric). Signal processing: amplification, display, data analysis. Key characteristics: specificity (from biological element), sensitivity (from transducer), speed, miniaturization.
- 6Biosensors – Applications in Pharma: (1) Glucose biosensor: glucose oxidase electrode → measures blood glucose (glucometer for diabetics — most commercially successful biosensor). GOD oxidizes glucose → H₂O₂ → electrochemically detected. (2) Drug monitoring: biosensors for therapeutic drug monitoring (antibiotics, immunosuppressants). (3) Quality control: detecting contaminants, pathogens in pharmaceutical products. (4) Drug discovery: biosensors for measuring drug-receptor binding kinetics (Biacore SPR — surface plasmon resonance). (5) Environmental monitoring: detecting pollutants, heavy metals. (6) Clinical diagnostics: pregnancy tests (hCG antibody), cardiac markers (Troponin), infectious disease (COVID-19 rapid antigen tests — lateral flow immunoassay).
- 7Protein Engineering: Modifying the amino acid sequence of a protein to improve its properties (stability, activity, specificity, solubility). Two approaches: (1) Rational design: based on known 3D structure — site-directed mutagenesis of specific amino acids. Requires structural knowledge (X-ray crystallography, NMR). Example: engineering Subtilisin (detergent protease) for better thermostability. (2) Directed evolution: mimics natural evolution in the lab — random mutagenesis (error-prone PCR) → screen large libraries for improved variants → iterative cycles. No structural knowledge needed. Example: engineering enzymes for organic synthesis, biofuel production. Applications: improved industrial enzymes, engineered antibodies, protein drugs with longer half-life.
- 8Industrial Enzyme Production: Microbes as enzyme factories (advantages: fast growth, easy genetic manipulation, scalable fermentation). Key industrial enzymes: Amylase (Bacillus subtilis, B. amyloliquefaciens): starch → maltose/glucose. Used in food, textile, brewing. Catalase (Aspergillus niger, bovine liver): H₂O₂ → H₂O + O₂. Food preservation. Peroxidase (Horseradish — HRP): diagnostic reagent in ELISA, immunohistochemistry. Lipase (Candida rugosa, Thermomyces): fat hydrolysis. Used in detergents, pharmaceutical synthesis. Protease (Bacillus licheniformis): protein hydrolysis. Largest industrial enzyme by sales (detergents). Penicillinase (β-lactamase, Bacillus cereus): hydrolyzes penicillin → used in penicillin allergy testing, microbiological assays.
- 9Basic Principles of Genetic Engineering: Genetic engineering = direct manipulation of an organism’s genome using DNA technology. Core concept: isolate a gene of interest → join it to a vector DNA → introduce into host organism → host expresses the foreign gene → produce desired protein. Tools: (1) Restriction endonucleases (molecular scissors — cut DNA at specific sequences). (2) DNA ligase (molecular glue — joins DNA fragments). (3) Vectors (carriers — plasmids, phages, cosmids, BACs, YACs). (4) Host organisms (E. coli, yeast, CHO cells). Steps: Gene isolation → Vector preparation → Ligation → Transformation → Selection → Expression → Purification.
Learning Objectives
Exam FAQs
Q1. What is the most important industrial application of immobilized enzymes?
The largest pharmaceutical application is immobilized Penicillin Acylase for producing 6-APA (6-aminopenicillanic acid) from Penicillin G. 6-APA is the core structure from which ALL semi-synthetic penicillins (Amoxicillin, Ampicillin, Cloxacillin, Piperacillin) are made. The immobilized enzyme can be reused thousands of times in a packed-bed reactor, making the process economically viable. The food industry equivalent is immobilized Glucose Isomerase for HFCS production.
Q2. How does a glucose biosensor work?
The glucose biosensor uses Glucose Oxidase (GOD) as the biological recognition element. GOD catalyzes: Glucose + O₂ → Gluconic acid + H₂O₂. The H₂O₂ produced is detected by an amperometric electrode (transducer) — it is oxidized at the electrode surface, generating a measurable current proportional to glucose concentration. Modern glucometers use a disposable test strip containing GOD and electrodes — a drop of blood is applied, current measured, and glucose level displayed in seconds.
Q3. What is the difference between Rational Design and Directed Evolution?
Rational design: you KNOW the protein structure and DESIGN specific mutations (site-directed mutagenesis) based on understanding of structure-function relationships. Requires: 3D structure, computational modeling. Precise but limited by our understanding. Directed evolution: you DON’T need structural knowledge — create millions of random mutants (error-prone PCR, DNA shuffling), then SCREEN for improved variants. Mimics natural evolution but accelerated. Won the 2018 Nobel Prize (Frances Arnold). Broader exploration of sequence space but requires high-throughput screening.